Background The proportion of patients infected with SARS-CoV-2 that are prescribed
antibiotics is uncertain, and may contribute to patient harm and global antibiotic resistance …

Background Bacterial co-pathogens are commonly identified in viral respiratory infections
and are important causes of morbidity and mortality. The prevalence of bacterial infection in …

Abstract Analysis of human blood immune cells provides insights into the coordinated
response to viral infections such as severe acute respiratory syndrome coronavirus 2, which …

Objectives To describe the clinical evolution and predictors of symptom persistence during 2
months' follow-up in adults with noncritical coronavirus disease 2019 (COVID-19). Methods …

Importance Evidence regarding corticosteroid use for severe coronavirus disease 2019
(COVID-19) is limited. Objective To determine whether hydrocortisone improves outcome for …

Antimicrobial resistance (AMR) is a serious threat to global public health. It increases
morbidity and mortality, and is associated with high economic costs due to its health care …

Objectives To assess the prevalence of and factors associated with post-coronavirus
disease 2019 (COVID-19) syndrome 6 months after the onset. Methods A bidirectional …

Background Long-term health sequelae of coronavirus disease 2019 (COVID-19) may be
multiple but have thus far not been systematically studied. Methods All patients discharged …

Objectives To summarise the evidence on the detection pattern and viral load of SARS-CoV-
2 over the course of an infection (including any asymptomatic or pre-symptomatic phase) …

Abstract The coronavirus disease (COVID-19) is seriously threatening world public health
security. Currently,> 200 countries and regions have been affected by the epidemic, with the …